Patent Licensing - Nanotechnology

Relevant Publications

Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response.

Issue Release: 2024

WIPO initiative of transforming traditional resources and sharing rights: An evolutionary game analysis and a Chinese context.

Issue Release: 2024

Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements.

Issue Release: 2024

The global patent landscape of emerging infectious disease monkeypox.

Issue Release: 2024

Lenacapavir to prevent HIV infection: current prices versus estimated costs of production.

Issue Release: 2024

Evolving intellectual property landscape for AI-driven innovations in the biomedical sector: opportunities in stable IP regime for shared success.

Issue Release: 2024

Scaling training facilities for patent and proprietary medicine vendors in Nigeria: insights and lessons learned for policy implication and future partnerships.

Issue Release: 2024

The CRISPR Cas patent files, part 1: Cas9 - Where to we stand at the 10 year halftime?

Issue Release: 2023

Compulsory licensing of patents.

Issue Release: 2023

Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.

Issue Release: 2023

Voluntary licensing of long-acting HIV prevention and treatment regimens: using a proven collaboration- and competition-based mechanism to rapidly expand at-scale, sustainable, quality-assured and affordable supplies in LMICs.

Issue Release: 2023

Predicaments during a period of health emergency: Waiving patent protections or innovative public procurement? The example of advance purchase agreements (APA) for COVID-19 vaccines.

Issue Release: 2022

Barriers to Worldwide Access for Paxlovid, a New Treatment for COVID-19.

Issue Release: 2022

What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review.

Issue Release: 2022

The COVID-19 pandemic and long-term incentives for developing vaccines: Patent law under stress.

Issue Release: 2022

Effects of incorporating public innovation intermediaries on technology transfer performance: evidence from patent licensing of Japan\'s .

Issue Release: 2022

Nigerian stakeholders\' perceptions of a pilot tier accreditation system for Patent and Proprietary Medicine Vendors to expand access to family planning services.

Issue Release: 2022

Intellectual Property Rights and Vaccines.

Issue Release: 2022

Exploring the role of R&D collaborations and non-patent IP policies in government technology transfer performance: Evidence from U.S. federal agencies (1999-2016).

Issue Release: 2022

[Fast track patent program for COVID-19 in BrazilProceso rápido de concesión de patentes para enfrentar la COVID-19 en Brasil].

Issue Release: 2022

How to Foster Investment in Nanotechnology R&D?

What is the Future of Spherical Nanoparticles?

What is Bismuth Telluride (Bi2Te3)?

How Does Nanotechnology Enhance Hydrotreating?

How Does Sol-Gel Process Work?

What Are the Current Challenges in Using Nanotechnology for Skin Cancer?

Why is the Terahertz Frequency Range Important?

Why Are Crystal Systems Important in Nanotechnology?

What is Supercritical CO2 Cleaning?

What are Flexible Standards in Nanotechnology?

Partnered Content Networks

Relevant Topics